카테고리 없음
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 06.23(금)
toucrew
2023. 8. 18. 15:20
반응형
Global Data Intelligence Center | ||
구분 | 보고서 (영문) | 업로드 날짜 |
제약/ 바이오/ 임상시험 |
Contract Manufacturing Opportunities and Threats, May 2023 | 06-02-2023 |
The Biologic Advantage European Pharma Sales Set to Surpass US Rivals by 2028 | 06-12-2023 | |
The Future of Pain Medication Are Cannabinoids the Solution to the Opioid Epidemic | 06-09-2023 | |
Study Shows World Health Organizations Revised Hepatitis B Vaccination Policy Is Effective | 06-07-2023 | |
질환별 | Alzheimer's Disease 68 Market Analysis and Sales Forecast | 06-15-2023 |
Venous Thromboembolism Market Projected to Grow at a CAGR of 2.6 Between 2022 and 2032 | 06-19-2023 | |
Pneumococcal Vaccines Competitive Landscape | 06-12-2023 | |
Systemic Scleros is Understanding Gender Differences of a Complex Disease | 06-07-2023 | |
Uncovering the Link Between Alzheimer's Disease and the Gut Microbiome | 06-19-2023 | |
컨퍼런스/ 심포지엄/ 학회 등 |
(ASCO 2023) Keytruda Becomes a New Option in Neo adjuvant Non Small Cell Lung Cancer | 06-03-2023 |
(ASCO 2023) AstraZeneca's PD-1 TIGIT Bispecific Shows Promise in Checkpoint Exposed NSCLC | 06-05-2023 | |
(ASCO 2023) Blockbuster Enhertu Demonstrates Efficacy Across Multiple Tumor Types | 06-06-2023 | |
(ASCO 2023) Exciting Phase II Efficacy Data for BMS' Breyanzi in CLL/SLL | 06-08-2023 | |
(ASCO 2023) Highlights Daiichi's and AstraZeneca's ADCs Demonstrate Impressive Efficacy Across Tumor Types | 06-09-2023 | |
(EHA 2023) Janssen's Talquetamab Shows Promise in Multiple Myeloma | 06-10-2023 | |
(EHA 2023) Iomab-B Outperforms Chemotherapy as a Pre-Allogeneic HCT Conditioning in Relapsed/Refractory AML | 06-10-2023 | |
(EHA 2023) REVIVE Study Results Reveal Positive Clinical Response in Polycythemia Vera | 06-11-2023 | |
(EHA 2023) Kura Oncology's Menin Inhibitor Ziftomenib Shows Impressive Phase I Results | 06-11-2023 |
반응형